Paclitaxel (PTX), a classic chemotherapy drug widely used to treat a variety of cancers, can not only upregulate the expression of p53 and p21 genes but also downregulate the expression of SLC7A11 and SLC1A5.135, 136. This evidence concerns the gene SLC7A11 and cancer.